Home > News content

43% of generic drugs approved by the US are not on sale

via:CnBeta     time:2019/2/11 22:31:32     readed:145

Experts say that there are many reasons why pharmaceutical companies put aside the approval of generic drugs. Including industry consolidation has made it harder to buy, manufacture and sell generics, generic manufacturers still face patent litigation by branded drug manufacturers, and branded drug manufacturers paying generic drug manufacturers to delay their listings.

In addition, internal decisions by generic manufacturers may also result in product shelving. The result is  The FDA did not see the competition they expected.

China IT News APP

Download China IT News APP

Please rate this news

The average score will be displayed after you score.

Post comment

Do not see clearly? Click for a new code.

User comments